NeuroStar TMS Therapy

Neuronetics ranked #8 Holder of Pervasive Neurotech Intellectual Property*

by

.

Neu­ro­net­ics received FDA clear­ance for Neu­roStar TMS Ther­a­py in 2008. Neu­roStar uses tran­scra­nial mag­net­ic stim­u­la­tion as a form of neu­ro­mod­u­la­tion to treat depres­sion in patients who have not respond­ed ade­quate­ly to oth­er depres­sion treat­ments. [Read more…] about Neu­ro­net­ics ranked #8 Hold­er of Per­va­sive Neu­rotech Intel­lec­tu­al Property*